The authors reported the identification of hepatitis C virus NS5A inhibitors Pibrentasvir and Ombitasvir as SARS-CoV-2 exonuclease inhibitors.
[Communications Biology]
Sorry, but the selected Zotpress account can't be found.
Home Newsletters Immunology of Infectious Disease News An IL-9–Pulmonary Macrophage Axis Defines the Allergic Lung Inflammatory Environment
